Functional characterization of a nucleoside-derived drug transporter variant (hCNT3C602R) showing altered sodium-binding capacity

Molecular Pharmacology

Volumn 73, Issue 2, 2008, Pages 379-386

  Errasti Murugarren, Ekaitz ^b   Cano Soldado, Pedro ^b   Pastor Anglada, Marçal ^b   Casado, Fco Javier ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CONCENTRATIVE NUCLEOSIDE TRANSPORTER 3; CYSTEINE DERIVATIVE; MEMBRANE PROTEIN; NUCLEOSIDE; NUCLEOSIDE TRANSPORTER; SERINE; SODIUM; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HILL REACTION; HUMAN; HUMAN CELL; KINETICS; MEMBRANE CHANNEL; MEMBRANE POLARIZATION AND DEPOLARIZATION; NUCLEOSIDE TRANSPORT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN ENGINEERING; SITE DIRECTED MUTAGENESIS; STOICHIOMETRY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BINDING SITES; DOGS; HELA CELLS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; NUCLEOSIDE TRANSPORT PROTEINS; POLYMORPHISM, GENETIC; SODIUM; VARIATION (GENETICS);

EID: 38549143917     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.041848     Document Type: Article

References (34)

1. Badagnani I, Chan W, Castro RA, Brett CM, Huang CC, Stryke D, Kawamoto M, Johns SJ, Ferrin TE, Carlson EJ, Burchard EG, and Giacomini KM (2005) Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3). Pharmacogenomics J 5:157-165.
2. Baldwin SA, Mackey JR, Cass CE, and Young JD (1999) Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today 5:216-224.
3. Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
4. Damaraju S, Zhang J, Visser F, Tackaberry T, Dufour J, Smith KM, Slugoski M, Ritzel MW, Baldwin SA, Young JD, et al. (2005) Identification and functional characterization of variants in human concentrative nucleoside transporter 3, hCNT3 (SLC28A3), arising from single nucleotide polymorphisms in coding regions of the hCNT3 gene. Pharmacogenet Genomics 15:173-182.
5. Damaraju VL, Elwi AN, Hunter C, Carpenter P, Santos C, Barron GM, Sun X, Baldwin SA, Young JD, Mackey JR, et al. (2007) Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney. Am J Physiol Renal Physiol 293:F200-F211.
6. del Santo B, Valdes R, Mata J, Felipe A, Casado FJ, and Pastor-Anglada M (1998) Differential expression and regulation of nucleoside transport systems in rat liver parenchymal and hepatoma cells. Hepatology 28:1504-1511.
7. Errasti-Murugarren E, Pastor-Anglada M and Casado FJ (2007) Role of CNT3 in the transepithelial flux of nucleosides and nucleoside-derived drugs. J Physiol 582:1249-1260.
8. Grantham R (1974) Amino acid difference formula to help explain protein evolution. Science 185:862-864.
9. Griffith DA and Jarvis SM (1996) Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1286:153-181.
10. +-nucleoside transport in brush border membrane vesicles from human kidney. Biochim Biophys Acta 1149:202-208.
11. Harris MJ, Kagawa T, Dawson PA, and Arias IM (2004) Taurocholate transport by hepatic and intestinal bile acid transporters is independent of FIC1 overexpression in Madin-Darby canine kidney cells. J Gastroenterol Hepatol 19:819-825.
12. Hu H, Endres CJ, Chang C, Umapathy NS, Lee EW, Fei YJ, Itagaki S, Swaan PW, Ganapathy V, and Unadkat JD (2006) Electrophysiological characterization and modeling of the structure activity relationship of the human concentrative nucleoside transporter 3 (hCNT3). Mol Pharmacol 69:1542-1553.
13. Jauch P and Lauger P (1986) Electrogenic properties of the sodium-alanine cotransporter in pancreatic acinar cells: II. Comparison with transport models. J Membr Biol 94:117-127.
14. Klamo EM, Drew ME, Landfear SM, and Kavanaugh MP (1996) Kinetics and stoichiometry of a proton/myo-inositol cotransporter. J Biol Chem 271:14937-14943.
15. Leabman MK, Huang CC, DeYoung J, Carlson EJ, Taylor TR, de la Cruz M, Johns SJ, Stryke D, Kawamoto M, Urban TJ, et al. (2003) Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci U S A 100:5896-5901.
16. +/glucose cotransporter SGLT2 reveal a common mechanism for SGLT1 and SGLT2. J Biol Chem 271:32678-32683.
17. Mangravite LM, Badagnani I, and Giacomini KM (2003) Nucleoside transporters in the disposition and targeting of nucleoside analogs in the kidney. Eur J Pharmacol 479:269-281.
18. Mata JF, Garcia-Manteiga JM, Lostao MP, Fernandez-Veledo S, Guillen-Gomez E, Larrayoz IM, Lloberas J, Casado FJ, and Pastor-Anglada M (2001) Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[Prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug. Mol Pharmacol 59:1542-1548.
19. Miller MP and Kumar S (2001) Understanding human disease mutations through the use of interspecific genetic variation. Hum Mol Genet 10:2319-2328.
20. Molina-Arcas M, Bellosillo B, Casado FJ, Montserrat E, Gil J, Colomer D, and Pastor-Anglada M (2003) Fludarabine uptake mechanisms in B-cell chronic lymphocytic leukemia. Blood 101:2328-2334.
21. Murph MM, Scaccia LA, Volpicelli LA, and Radhakrishna H (2003) Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2-and Rab5-dependent pathway. J Cell Sci 116:1969-1980.
22. Nagai K, Nagasawa K, and Fujimoto S (2005) Uptake of the anthracycline pirarubicin into mouse M5076 ovarian sarcoma cells via a sodium-dependent nucleoside transport system. Cancer Chemother Pharmacol 55:222-230.
23. +-nucleoside transporters in the human intestine. Am J Physiol Gastrointest Liver Physiol 280:G475-G481.
24. Pastor-Anglada M, Cano-Soldado P, Molina-Arcas M, Lostao MP, Larrayoz I, Martinez-Picado J, and Casado FJ (2005) Cell entry and export of nucleoside analogues. Virus Res 107:151-164.
25. Pastor-Anglada M, Felipe A, and Casado FJ (1998) Transport and mode of action of nucleoside derivatives used in chemical and antiviral therapies. Trends Pharmacol Sci 19:424-430.
26. +- nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem 276:2914-2927.
27. Rodríguez-Mulero S, Errasti-Murugarren E, Ballarin J, Felipe A, Doucet A, Casado FJ, and Pastor-Anglada M (2005) Expression of concentrative nucleoside transporters SLC28 (CNT1, CNT2, and CNT3) along the rat nephron: effect of diabetes. Kidney Int 68:665-672.
28. Sarkar M, Han T, Damaraju V, Carpenter P, Cass CE, and Agarwal RP (2005) Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells. Biochem Pharmacol 70:426-432.
29. +/ nucleoside cotransporter (hCNT3) exhibits novel cation-coupled nucleoside transport characteristics. J Biol Chem 280:25436-25449.
30. Toan SV, To KK, Leung GP, de Souza MO, Ward JL, and Tse CM (2003) Genomic organization and functional characterization of the human concentrative nucleoside transporter-3 isoform (hCNT3) expressed in mammalian cells. Pflugers Arch 447:195-204.
31. Volpicelli LA, Lah JJ, and Levey AI (2001) Rab5-dependent trafficking of the m4 muscarinic acetylcholine receptor to the plasma membrane, early endosomes, and multivesicular bodies. J Biol Chem 276:47590-47598.
32. Yamamoto T, Kuniki K, Takekuma Y, Hirano T, Iseki K, and Sugawara M (2007) Ribavirin uptake by cultured human choriocarcinoma (BeWo) cells and Xenopus laevis oocytes expressing recombinant plasma membrane human nucleoside transporters. Eur J Pharmacol 557:1-8.
33. -dependent neurotransmitter transporters. Nature 437:215-223.
34. Zhang J, Tackaberry T, Ritzel MW, Raborn T, Barron G, Baldwin SA, Young JD, and Cass CE (2006) Cysteine-accessibility analysis of transmembrane domains 11-13 of human concentrative nucleoside transporter 3. Biochem J 394:389-398.